AzTrials
AzTrials

HypnosisCATALHYPNOANINCT05306262

Interest of Catalepsy in the Hypnotic Trance

A study testing Hypnosis session and Catalepsy in people with Hypnosis, run by CMC Ambroise Paré at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Catalepsy seems to facilitate hypnotic induction and deepen hypnotic trance, although no work confirms the usefulness of this technique which is in common use in hypnosis. Furthermore, it has been shown that the hypnotic trance state is accompanied by an increase in parasympathetic tone, the non-invasive measurement… Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Hypnosis
What is being tested?
Hypnosis session and Catalepsy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteFrance
Study dates
26 May 2022to 28 May 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy Volunteers
  • Consent for participation
  • Affiliation to the social security system

Who cannot join

  • Arrhythmia (atrial fibrillation, pacemaker, defibrillator)
  • Autonomic nervous system disorder (paraplegia, epilepsy, etc.)
  • Pregnant or breastfeeding woman
  • Patients under protection of the adults (guardianship, curators or safeguard of justice)
  • Communication difficulties

Trial locations and contacts

1 site in 1 country.

France1 site
  • Institut Emergences

    Rennes

Other trials in France

About this study

Official title: Effects of Catalepsy on the Parasympathetic Tone Assessed by ANI (Analgesia/Nociception Index) and on Absorption, Dissociation and Perception of Time During the Hypnotic Trance.

Catalepsy seems to facilitate hypnotic induction and deepen hypnotic trance, although no work confirms the usefulness of this technique which is in common use in hypnosis. Furthermore, it has been shown that the hypnotic trance state is accompanied by an increase in parasympathetic tone, the non-invasive measurement of which is easy by the ANI monitor (Analgesia Nociception Index).

The research hypothesis is that, by adding a body dissociation, catalepsy could facilitate and intensify the hypnotic trance, the intensity of which can be monitored and is proportional to the parasympathetic tone.

Read the detailed description

After randomization, subjects will either benefit from the normal hypnotic trance, or from the hypnotic trance associated with catalepsy of the hand.

T0 = installation in a sitting position and collection of an accompanying theme T1 = induction of the hypnotic trance (closing eyes) with restitution of the theme to the patient and suggestion of comfort over a period of 5 to 10 min T2 = validation of comfort by a pre-established signal T3 = return to consciousness (opening eyes) T4 = end of questionnaire about absorption, dissociation and time perception

Conditions
Hypnosis
Being tested
Hypnosis session, Catalepsy
Keywords
Hypnosis, Catalepsy, Parasympathetic tone, Absorption, Dissociation, Perception of time
Medical subject headings
Catalepsy, Dissociative Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hypnosis sessionProcedure or surgery

    Comfort hypnosis: accompaniment of a pleasant memory.

  • CatalepsyOther

    Catalepsy of the hand.

Study groups in NCT05306262
Study groupRoleWhat they receive
hypnotic tranceActive comparatorHypnosis session of comfort for 20 minutes
Receives: Procedure: Hypnosis session
hypnotic trance + catalepsyExperimentalCatalepsy + Hypnosis session of comfort for 20 minutes
Receives: Procedure: Hypnosis session; Other: Catalepsy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Parasympathetic tone

    Analgesia Nociception Index (ANI)

    Measured: 30 minutes

Secondary outcomes (5)
  1. Absorption

    Numeric scale from 0 to 10 (0=not at all, 10=completely)

    Measured: 30 minutes

  2. Dissociation

    Numeric scale from 0 to 10 (0=completely in the reality, 10=completely disconnected from reality)

    Measured: 30 minutes

  3. Time perception (minute)

    Difference between the time of hypnosis session estimated by the patient and the actual time of hypnosis session (from closing to opening the eyes).

    Measured: 30 minutes

  4. Variation of Heart Rate (beat per minute)

    Heart rate measured by a pulse oximeter

    Measured: 30 minutes

  5. Variation of Respiratory Rate (breath per minute)

    Respiratory rate assessed by the investigator

    Measured: 30 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Apr 2022
  2. Study start26 May 2022
  3. Primary completion28 May 2022
  4. Study completion28 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05306262
Sponsor's protocol ID
2020/03
Acronym
CATALHYPNOANI
Status last verified
Apr 2026
First submitted
23 Mar 2022
Last updated
8 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Boselli E, Radoykov S, Paqueron X, Virot C. Effects of hand catalepsy on subjective trance perception and relative parasympathetic tone in healthy volunteers during pleasant hypnotic session: a randomized controlled study. J Clin Monit Comput. 2024 Dec;38(6):1291-1296. doi: 10.1007/s10877-024-01178-7. Epub 2024 May 29.

    PubMed 38811463

Questions about this trial

What is this clinical trial studying?

A study testing Hypnosis session and Catalepsy in people with Hypnosis, run by CMC Ambroise Paré at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Parasympathetic tone (time frame: 30 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05306262, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in